Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine versus oral midazolam premedication in children undergoing tonsil/adenoid surgery
ChiCTR2400082238Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and midazolam in Postoperative behavioral change, Emergence agitation (EA) and preoperative anxiety (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Incidence of postoperative negative behavior changes. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
Postoperative behavioral changeEmergence agitation (EA)preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2400082238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082238.